Virtu KCG Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$5.45M Buy
28,959
+6,542
+29% +$1.18M 0.15% 55
2017
Q1
$3.71M Buy
22,417
+11,931
+114% +$1.9M 0.1% 101
2016
Q4
$1.51M Sell
10,486
-5,255
-33% -$704K 0.04% 466
2016
Q3
$1.97M Sell
15,741
-176
-1% -$22.7K 0.05% 315
2016
Q2
$2.09M Sell
15,917
-6,905
-30% -$945K 0.04% 321
2016
Q1
$3.17M Buy
22,822
+19,211
+532% +$2.57M 0.09% 146
2015
Q4
$504K Sell
3,611
-12,656
-78% -$1.74M 0.01% 1533
2015
Q3
$2.28M Sell
16,267
-5,044
-24% -$758K 0.04% 382
2015
Q2
$3.5M Buy
21,311
+3,356
+19% +$536K 0.06% 229
2015
Q1
$2.77M Buy
17,955
+8,755
+95% +$1.25M 0.06% 249
2014
Q4
$1.16M Sell
9,200
-2,441
-21% -$302K 0.02% 820
2014
Q3
$1.39M Buy
11,641
+722
+7% +$82.8K 0.03% 709
2014
Q2
$1.18M Sell
10,919
-36,451
-77% -$3.76M 0.02% 1018
2014
Q1
$4.72M Buy
47,370
+28,071
+145% +$2.54M 0.06% 280
2013
Q4
$1.78M Sell
19,299
-29,378
-60% -$2.61M 0.02% 745
2013
Q3
$4.07M Buy
+48,677
New +$4.17M 0.05% 289

Other funds holding ELV

Virtu KCG Holdings's ELV Position: Q2 2017 in Review

Virtu KCG Holdings increased its Elevance Health (ELV) stake by 29% in Q2 2017, buying an estimated $1.18M and bringing the position to 28,959 shares worth $5.45M. The position accounts for 0.15% of the portfolio, ranked #55.

Virtu KCG Holdings first reported a position in ELV in Q3 2013 and has held it in 16 quarters since. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Virtu KCG Holdings held 28,959 shares of Elevance Health worth $5.45M as of Q2 2017.
  • Virtu KCG Holdings bought 6,542 Elevance Health shares in Q2 2017, an estimated $1.18M.
  • Elevance Health made up 0.15% of Virtu KCG Holdings's portfolio in Q2 2017, its #55 holding.
  • Virtu KCG Holdings first reported a position in Elevance Health in Q3 2013 and has held it in 16 quarters since.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.